Dartmouth has been designated as a Center of Cancer Nanotechnology Excellence (CCNE) with a grant from the National Cancer Institute (NCI). The CCNE places Dartmouth among top centers in cancer nanotechnology research nationwide and takes full advantage of Dartmouth's culture of cross-disciplinary collaboration. CCNEs are tasked with integrating nanotechnology into basic and applied cancer research in order to provide new solutions for the diagnosis and treatment of cancer.
The Dartmouth Center of Cancer Nanotechnology Excellence focuses on the development and optimization of novel antibody-tagged iron-core magnetic nanoparticles activated through alternating magnetic field exposure for the treatment of solid tumors in the breast and ovary.
Role: Assistant to the DCCNE Director